Basic Fibroblast Growth Factor (bFGF)-Overexpressed Bone Marrow Mesenchymal Stem Cells (BMSCs) Orchestrate Lung Cancer Development and Fibroblast Growth

Author:

Yang Weidong1,Li Lei1,Jia Jiangtao2,Wang Zhibao3,Zang Hanqing4

Affiliation:

1. Department of X-ray, The No. 2 Hospital of Baoding, No. 338 Dongfeng West Road, Baoding, Hebei, 072750, China

2. Department of Digestive System, The No. 2 Hospital of Baoding, No. 338 Dongfeng West Road, Baoding, Hebei, 072750, China

3. Department of Nuclear Magnetic Resonance Room, The No. 2 Hospital of Baoding, No. 338 4Dongfeng West Road, Baoding, Hebei, 072750, China

4. Department of ICU, The No. 2 Hospital of Baoding, No. 338 Dongfeng West Road, Baoding, Hebei, 072750, China

Abstract

Lung cancer is one of most common cancer with a complicated pathogenesis and a poor prognosis. This study aimed to investigate the role of bFGF and BMSCs in lung cancer progression. BMSCs were transfected with bFGF mimic or NC and then co-cultured with lung cancer cells followed by measuring cell migration by Transwell assay and proliferation by CCK-8 assay, expression of bFGF, E-cadherin, and Vimentin by RT-qPCR and Western blot. The BMSCs were positive for CD90, CD71, CD29 and CD45. Overexpression of bFGF in BMSCs resulted in increased lung cancer cell proliferation at 24 h, 48 h and 72 h. Meanwhile, bFGF overexpression also significantly promoted cell migration and invasion as well as upregulated bFGF (4.03±0.36 ng/μl) and E-cadherin (3.64±0.27 ng/μl) and downregulated Vimentin (1.45±0.19 ng/μl). In conclusion, co-culture of BMSCs overexpressing bFGF and lung cancer cells enhances BMSCs differentiation and promotes cancer cell development possibly through regulation of E-cadherin and Vimentin expression, indicating that this might be a novel approach for the treatment of lung cancer.

Publisher

American Scientific Publishers

Subject

Biomedical Engineering,Medicine (miscellaneous),Bioengineering,Biotechnology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3